384 related articles for article (PubMed ID: 30745454)
1. Loss of stretch-activated channels, PIEZOs, accelerates non-small cell lung cancer progression and cell migration.
Huang Z; Sun Z; Zhang X; Niu K; Wang Y; Zheng J; Li H; Liu Y
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30745454
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of STIM1 expression inhibits non-small-cell lung cancer cell proliferation
Ge C; Zeng B; Li R; Li Z; Fu Q; Wang W; Wang Z; Dong S; Lai Z; Wang Y; Xue Y; Guo J; Di T; Song X
Bioengineered; 2019 Dec; 10(1):425-436. PubMed ID: 31564210
[TBL] [Abstract][Full Text] [Related]
3. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
4. Aldolase A promotes proliferation and G
Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
[TBL] [Abstract][Full Text] [Related]
5. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
Ma S; Wang X; Zhang Z; Liu D
Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients.
Schlensog M; Magnus L; Heide T; Eschenbruch J; Steib F; Tator M; Kloten V; Rose M; Noetzel E; Gaisa NT; Knüchel R; Dahl E
Epigenetics; 2018; 13(3):214-227. PubMed ID: 27623992
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide identification of transcription factors that are critical to non-small cell lung cancer.
Zhang DL; Qu LW; Ma L; Zhou YC; Wang GZ; Zhao XC; Zhang C; Zhang YF; Wang M; Zhang MY; Yu H; Sun BB; Gao SH; Cheng X; Guo MZ; Huang YC; Zhou GB
Cancer Lett; 2018 Oct; 434():132-143. PubMed ID: 30031117
[TBL] [Abstract][Full Text] [Related]
8. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
[TBL] [Abstract][Full Text] [Related]
9. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
[TBL] [Abstract][Full Text] [Related]
10. Recombinant cell-permeable HOXA9 protein inhibits NSCLC cell migration and invasion.
Yu SL; Koo H; Lee HY; Yeom YI; Lee DC; Kang J
Cell Oncol (Dordr); 2019 Jun; 42(3):275-285. PubMed ID: 30697674
[TBL] [Abstract][Full Text] [Related]
11. CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer.
Zhao H; Wang J; Kong X; Li E; Liu Y; Du X; Kang Z; Tang Y; Kuang Y; Yang Z; Zhou Y; Wang Q
Sci Rep; 2016 Jul; 6():29719. PubMed ID: 27411490
[TBL] [Abstract][Full Text] [Related]
12. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway.
Qian Y; Du Z; Xing Y; Zhou T; Chen T; Shi M
Mol Med Rep; 2017 Nov; 16(5):6034-6040. PubMed ID: 28849037
[TBL] [Abstract][Full Text] [Related]
13. WDR1 Promotes Cell Growth and Migration and Contributes to Malignant Phenotypes of Non-small Cell Lung Cancer through ADF/cofilin-mediated Actin Dynamics.
Yuan B; Zhang R; Hu J; Liu Z; Yang C; Zhang T; Zhang C
Int J Biol Sci; 2018; 14(9):1067-1080. PubMed ID: 29989053
[TBL] [Abstract][Full Text] [Related]
14. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
15. Effects of MALAT1 on proliferation and apo- ptosis of human non-small cell lung cancer A549 cells in vitro and tumor xenograft growth in vivo by modulating autophagy.
Ma J; Wu K; Liu K; Miao R
Cancer Biomark; 2018; 22(1):63-72. PubMed ID: 29439314
[TBL] [Abstract][Full Text] [Related]
16. 17β-estradiol upregulates IL6 expression through the ERβ pathway to promote lung adenocarcinoma progression.
Huang Q; Zhang Z; Liao Y; Liu C; Fan S; Wei X; Ai B; Xiong J
J Exp Clin Cancer Res; 2018 Jul; 37(1):133. PubMed ID: 29970138
[TBL] [Abstract][Full Text] [Related]
17. p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
Gu MM; Gao D; Yao PA; Yu L; Yang XD; Xing CG; Zhou J; Shang ZF; Li M
Cancer Sci; 2018 Dec; 109(12):3783-3793. PubMed ID: 30281878
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
19. SNHG20 knockdown suppresses proliferation, migration and invasion, and promotes apoptosis in non-small cell lung cancer through acting as a miR-154 sponge.
Lingling J; Xiangao J; Guiqing H; Jichan S; Feifei S; Haiyan Z
Biomed Pharmacother; 2019 Apr; 112():108648. PubMed ID: 30780105
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
